1)幕内博康,町村貴郎,杉原隆,他.食道粘膜癌の内視鏡診断と治療.消内視鏡 2 : 447-452, 1990
2)門馬久美子,榊信廣,吉田操.食道粘膜癌の内視鏡的治療─内視鏡的粘膜切除を中心に.消内視鏡 2 : 501-506, 1990
3)小野裕之,後藤田卓志,山口肇,他.ITナイフを用いたEMR─適応拡大の工夫.消内視鏡 11 : 675-681, 1999.
4)小山恒男,菊池勇一,友利彰寿,他.食道癌に対するEMRの選択方法 ; 新しいEMR手技─Hooking EMR methodの有用性.臨消内科 16 : 1609-1615, 2001
5)Ishihara R, Iishi H, Takeuchi Y, et al. Local recurrence of large squamous cell carcinoma of the esophagus after endoscopic resection. Gastrointest Endosc 67 : 799-804, 2008
6)Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70 : 860-866, 2009
7)Takahashi H, Arimura Y, Masao H, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus(with video). Gastrointest Endosc 72 : 255-264, 2010
8)日本食道学会(編).食道癌取扱い規約,10版補訂版.金原出版,2008
9)日本食道学会(編).食道癌診断・治療ガイドライン,2012年4月版(3版).金原出版,2012
10)Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus : a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123 : 432-439, 1998
11)小山恒男,宮田佳典,島谷茂樹,他.転移のあったm3・sm1食道癌の特徴.胃と腸 37 : 71-74, 2002
12)Katada C, Muto M, Momma K, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae-a multicenter retrospective cohort study. Endoscopy 39 : 779-783, 2007
13)Shimizu Y, Tsukagoshi H, Fujita M, et al. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 56 : 387-390, 2002
14)Yamashina T, Ishihara R, Nakai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol 2013(In press).
15)Muto M, Hironaka S, Nakane M, et al. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer. Gastrointest Endosc 56 : 517-521, 2002
16)Muto M, Takahashi M, Ohtsu A, et al. Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region. Carcinogenesis 26 : 1008-1012, 2005
17)Hori K, Okada H, Kawahara Y, et al. Lugol-voiding lesions are an important risk factor for a second primary squamous cell carcinoma in patients with esophageal cancer or head and neck cancer. Am J Gastroenterol 106 : 858-866, 2011
18)堅田親利,武藤学.背景因子からみた異時性多発食道癌の長期経過.胃と腸 42 : 1355-1363, 2007